CCEL Cryo Cell International Dashboard

Founded in 1989, Cryo-Cell International Inc. is the world’s first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby’s cord blood and cord tissue stem cells. In addition to its family bank, Cryo-Cell International has a public banking program in partnership with Duke University. Cryo-Cell’s public bank has provided cord blood for more than 600 transplantations and operates cord blood donation sites across the U.S in prominent hospitals such as Cedars–Sinai Hospital in Los Angeles and Baptist Hospital in Miami. Cryo-Cell’s mission is to provide clients withstate-of-the-art cord blood and cord tissue cryopreservation services, raise awareness of the opportunity for expectant parents to bank or donate their baby’s cord blood and support the advancement of regenerative medicine. Cryo-Cell operates in a facility that is FDA registered, cGMP-/cGTP-compliant and licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. In addition, Cryo-Cell is ISO 13485:2003–certified by TÜV, an internationally recognized, quality assessment organization. Cryo-Cell is a publicly traded company, OTCQB:CCEL. For more information, please visit www.cryo-cell.com.

Company profile

Ticker

CCEL

Exchange

OTC

Website

www.cryo-cell.com

CEO

Mark L. Portnoy / David I. Portnoy

Incorporated

Delaware

Location

Florida

Fiscal year end

Nov 30

Sector

Health Services > Services to the Health Industry

Industry (SIC)

Services - Misc Health & Allied Services, NEC

Fresenius Medical Care AG & Co. KGaA • DaVita • Sotera Health • American Renal Associates • Tivity Health • Agilon Health • Global Cord Blood • Caladrius Biosciences • SOC Telemed • Progyny ...

SEC CIK

0000862692

Corporate docs

Articles of Incorporation & Bylaws

IRS number

223023093

CCEL stock data

S&P 500

1M 1Y 2Y 5Y

Calendar

14 Apr 21

13 Jun 21

30 Nov 21

Financial summary

Financial statements Chart CCEL financial data

Quarter (USD)	Feb 21	Nov 20	Aug 20	May 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Nov 20	Nov 19	Nov 18	Nov 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Recent insider trades

CCEL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
27 May 21	Portnoy David	Common Stock	Buy	Aquire P	Yes	No	8.65	946	8.18K	98,162
24 May 21	Portnoy David	Common Stock	Option exercise	Aquire M	No	No	2.9	32,184	93.33K	748,156
24 May 21	Portnoy David	Common Stock	Option exercise	Aquire M	No	No	1.72	200,000	344K	715,972
24 May 21	Portnoy David	Stock Option Common Stock	Option exercise	Dispose M	No	No	2.9	32,184	93.33K	67,816
24 May 21	Portnoy David	Stock Option Common Stock	Option exercise	Dispose M	No	No	1.72	200,000	344K	0
24 May 21	Portnoy Mark L.	Common Stock	Option exercise	Aquire M	No	No	2.9	32,184	93.33K	719,698
24 May 21	Portnoy Mark L.	Common Stock	Option exercise	Aquire M	No	No	1.72	200,000	344K	687,514
24 May 21	Portnoy Mark L.	Stock Option Common Stock	Option exercise	Dispose M	No	No	2.9	32,184	93.33K	67,816
24 May 21	Portnoy Mark L.	Stock Option Common Stock	Option exercise	Dispose M	No	No	1.72	200,000	344K	0
21 May 21	Portnoy David	Common Stock	Buy	Aquire P	No	No	8.46	1,000	8.46K	515,972

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

CCEL institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

4.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	0	NEW
Opened positions	1	0	NEW
Closed positions	0	1	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	3.82M	0	NEW
Total shares	496.5K	0	NEW
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Iszo Capital	496.5K	$3.82M	NEW

Largest transactions	Shares	Bought/sold	Change
Iszo Capital	496.5K	+496.5K	NEW

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Athersys • Natera

Management Discussion

Revenues. Revenues for the three months ended February 28, 2021 were $6,860,617 compared to $7,620,774 for the same period in 2020, a 10% decrease. The decrease in revenue was primarily attributable to a 9% decrease in processing and storage fees.
Processing and Storage Fees. The decrease in processing and storage fee revenue is attributable to a decrease in the number of new domestic cord blood specimens offset by a 9% increase in recurring annual storage fee revenue.
Public Banking Revenue. For the three months ended February 28, 2021, revenue from public banking was $83,986 compared to $154,079 for the three months ended February 29, 2020.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: administer, anniversary, autism, biopharmaceutical, buying, cerebral, core, cure, decline, declining, delay, Disorder, educational, equal, expertise, exploit, explore, extend, extended, field, fourth, Hedging, immunomodulatory, import, infusion, introducing, irrevocable, milestone, minimum, mitigate, mitigation, palsy, perpetual, Phase, proprietary, purpose, reached, recovery, regenerative, regulatory, rolling, smaller, sooner, Spectrum, speed, sublicense, technical, triad, trial, varying, volume, xxix, xxx

Removed: acquiring, affirmative, al, alleging, amounted, answer, behalf, bone, breached, Brotherson, CaresTM, Certification, Circuit, cloud, committee, complaint, comprehensive, computing, counterclaim, County, court, defendant, develop, Document, duly, evaluated, expanding, Gary, geographic, hosting, implementation, implementing, independent, installment, Instance, investigation, issue, jill, Judicial, jurisdictional, Label, lieu, Linkbase, lump, myeloablative, nonemployee, notice, opted, pending, personal, procedure, purportedly, reconstitution, record, registrant, relation, Schema, served, Simplifying, styled, sum, surrendered, Taxonomy, thereunto, unamortized, undersigned, violation, withheld, XBRL

From filing 10-Q 2021 Q1